DGX vs SAM · P/E 22, rev $9.87B vs rev $2.01B
Quest Diagnostics Incorporated (DGX) versus Boston Beer Company Inc (SAM) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. SAM currently screens at market cap $1.79B.
Not investment advice. Open the DGX and SAM stock pages for the full models.
Not investment advice.